Patient Guide: Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 164 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06350097
Status: 🟢 Enrolling Now
Condition: Non-small Cell Lung Cancer
Phase: PHASE3

Where You Can Participate

This study is available at 164 locations across the country.

Top locations include:
  • • Fountain Valley, California
  • • Los Alamitos, California
  • • Los Angeles, California
  • • And 161 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer - Join Clinical Trial NCTNCT06350097

How to Join This Clinical Trial - NCTNCT06350097

Learn how to participate in this PHASE3 trial studying an investigational therapy for Non-small Cell Lung Cancer. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Non-small Cell Lung Cancer. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Non-small Cell Lung Cancer
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06350097 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 164 locations. Find a study site near you:

Clinical Research Site

Fountain Valley, California 92708 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Los Alamitos, California 90720 - United States

Status: RECRUITING

Clinical Research Site

Los Angeles, California 90017 - United States

Status: RECRUITING

Clinical Research Site

Los Angeles, California 90033 - United States

Status: RECRUITING

Clinical Research Site

Orange, California 92868 - United States

Status: WITHDRAWN

Clinical Research Site

San Diego, California 92123 - United States

Status: RECRUITING

Clinical Research Site

Santa Monica, California 90404 - United States

Status: RECRUITING

Clinical Research Site

Walnut Creek, California 94598 - United States

Status: RECRUITING

Clinical Research Site

New Haven, Connecticut 06510 - United States

Status: RECRUITING

Clinical Research Site

Washington D.C., District of Columbia 20037 - United States

Status: WITHDRAWN

And 154 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Non-small Cell Lung Cancer:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships